{"transactions":[{"id":729120,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":729119,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":729118,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":729117,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":124806,"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":1102612,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1102611,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1102610,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1102609,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":95206,"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1472001,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:59:55.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.44,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-24-076379","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017024076379/ownership.xml","form_type":"4"}},{"id":1472000,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-21T21:59:55.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-24-076379","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017024076379/ownership.xml","form_type":"4"}},{"id":1471999,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T21:59:55.000Z","date":"2024-06-20","kind":"sale","planned":false,"acquired":false,"shares":17544,"price":3.4852,"value":61144.3488,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive."}],"balance_after":65606,"source":{"system":"sec-edgar","filing":"0000950170-24-076379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017024076379/ownership.xml","form_type":"4"}},{"id":1475237,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-18T21:00:09.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":false,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units do not have an expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000950170-24-074986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017024074986/ownership.xml","form_type":"4"}},{"id":1475236,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T21:00:09.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":83150,"source":{"system":"sec-edgar","filing":"0000950170-24-074986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017024074986/ownership.xml","form_type":"4"}},{"id":1847802,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T20:05:27.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":46750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":46750,"derivative":{"exercise_price":4.12,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":46750},"source":{"system":"sec-edgar","filing":"0000899243-23-016128","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000089924323016128/doc4.xml","form_type":"4"}},{"id":1847801,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-21T20:05:27.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":33150,"derivative":{"underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000899243-23-016128","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000089924323016128/doc4.xml","form_type":"4"}},{"id":2225400,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T23:45:17.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":61264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":61264,"derivative":{"exercise_price":6.5,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":61264},"source":{"system":"sec-edgar","filing":"0000899243-22-023496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000089924322023496/doc4.xml","form_type":"4"}},{"id":2660952,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T21:36:56.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":34025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":34025,"derivative":{"exercise_price":23.39,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":34025},"source":{"system":"sec-edgar","filing":"0000899243-21-025049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000089924321025049/doc4.xml","form_type":"4"}},{"id":2997442,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-30T21:43:37.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 36 equal monthly installments following October 29, 2020."}],"balance_after":80000,"derivative":{"exercise_price":24,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-20-029956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000089924320029956/doc4.xml","form_type":"4"}}]}